ResMed Inc. (NYSE: RMD) last traded at $231.52, up 1.35% on the session. The quote above updates while this page is open; the figures below are drawn from ResMed Inc.’s own filings and are restated only when a new one is published.
ResMed Inc. trades on NYSE under the ticker RMD. Its market capitalisation is $33.40 billion.
Valuation measures for ResMed Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $33.40B |
|---|---|
| Enterprise value | $34.31B |
| P/E ratio | 22.20 |
| Price / sales | 5.91 |
| Price / book | 5.07 |
| Beta | 0.45 |
Trailing-twelve-month figures tagged in ResMed Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $5.65B |
|---|---|
| Net income (TTM) | $1.52B |
| EPS (TTM) | $10.43 |
| Gross margin | 61.06% |
| Operating margin | 33.37% |
| Return on equity | 23.13% |
| Cash | $1.47B |
Range and volume for RMD over the past 52 weeks.
| 52-week high | $293.58 |
|---|---|
| 52-week low | $180.27 |
| Volume | 925.8K |
| Average volume | 1.55M |
| Previous close | $228.44 |
Dividend history for ResMed Inc. over the trailing twelve months.
| Dividend yield | 1.04% |
|---|---|
| Dividend per share (TTM) | $2.40 |
| Payout ratio | 23.01% |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.